1461052516-207e4b0d-15a2-4e06-8a3a-dc840edbf706

1. A compound selected from Formula I, an N-oxide or an agriculturally suitable salt thereof,
wherein
R1 is cyclopropyl optionally substituted with 1-5 R5, isopropyl optionally substituted with 1-5 R6, or phenyl optionally substituted with 1-3 R7;
R2 is ((O)jC(R15)(R16))kR;
R is CO2H or a herbicidally effective derivative of CO2H;
R3 is halogen, cyano, nitro, OR20, SR21 or N(R22)R23;
R4 is \u2014N(R24)R25 or \u2014NO2;
each R5 and R6 is independently halogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C1-C3 alkoxy, C1-C2 haloalkoxy, C1-C3 alkylthio or C1-C2 haloalkylthio;
each R7 is independently halogen, cyano, nitro, C1-4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C4 hydroxyalkyl, C2-C4 alkoxyalkyl, C2-C4 haloalkoxyalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C3-C4 alkynyl, C3-C4 haloalkynyl, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyloxy, C2-C4 haloalkenyloxy, C3-C4 alkynyloxy, C3-C4 haloalkynyloxy, C1-C4 alkylthio, C1-C4 haloalkylthio, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C2-C4 alkenylthio, C2-C4 haloalkenylthio, C2-C4 alkenylsulfinyl, C2-C4 haloalkenylsulfinyl, C2-C4 alkenylsulfonyl, C2-C4 haloalkenylsulfonyl, C3-C4 alkynylthio, C3-C4 haloalkynylthio, C3-C4 alkynylsulfinyl, C3-C4 haloalkynylsulfinyl, C3-C4 alkynylsulfonyl, C3-C4 haloalkynylsulfonyl, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C4-C6 (alkyl)cycloalkylamino, C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-C6 trialkylsilyl, phenyl, phenoxy and 5- or 6-membered heteroaromatic rings, each phenyl, phenoxy and 5- or 6-membered heteroaromatic ring optionally substituted with one to three substituents independently selected from R45; or
two adjacent R7 are taken together as \u2014OCH2O\u2014, \u2014CH2CH2O\u2014, \u2014OCH(CH3)O\u2014, \u2014OC(CH3)2O\u2014, \u2014OCF2O\u2014, \u2014CF2CF2O\u2014, \u2014OCF2CF2O\u2014 or \u2014CH\u2550CH\u2014CH\u2550CH\u2014;
R15 is H, halogen, C1-C4 alkyl, C1-C4 haloalkyl, hydroxy, C1-C4 alkoxy or C2-C4 alkylcarbonyloxy;
R16 is H, halogen, C1-C4 alkyl or C1-C4 haloalkyl; or
R15 and R16 are taken together as an oxygen atom to form, with the carbon atom to which they are attached, a carbonyl moiety;
R20 is H, C1-C4 alkyl or C1-C3 haloalkyl;
R21 is H, C1-C4 alkyl or C1-C3 haloalkyl;
R22 and R23 are independently H or C1-C4 alkyl;
R24 is H, C1-C4 alkyl optionally substituted with 1-2 R30, C2-C4 alkenyl optionally substituted with 1-2 R31, or C2-C4 alkynyl optionally substituted with 1-2 R32; or R24 is C(\u2550O)R33, nitro, OR34, S(O)2R35, N(R36)R37 or N\u2550C(R62)R63;
R25 is H, C1-C4 alkyl optionally substituted with 1-2 R30 or C(\u2550O)R33; or
R24 and R25 are taken together as a radical selected from \u2014(CH2)4\u2014, \u2014(CH2)5\u2014, \u2014CH2CH\u2550CHCH2\u2014 and \u2014(CH2)2O(CH2)2\u2014, each radical optionally substituted with 1-2 R38; or
R24 and R25 are taken together as \u2550C(R39)N(R40)R41 or \u2550C(R42)OR43;
each R30, R31 and R32 is independently halogen, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 haloalkylthio, amino, C1-C3 alkylamino, C2-C4 dialkylamino or C2-C4 alkoxycarbonyl;
each R33 is independently H, C1-C14 alkyl, C1-C3 haloalkyl, C1-C4 alkoxy, phenyl, phenoxy or benzyloxy;
R34 is H, C1-C4 alkyl, C1-C3 haloalkyl or CHR66C(O)OR67;
R35 is C1-C4 alkyl or C1-C3 haloalkyl;
R36 is H, C1-C4 alkyl or C(\u2550O)R64;
R37 is H or C1-C4 alkyl;
each R38 is independently halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 haloalkylthio, amino, C1-C3 alkylamino, C2-C4 dialkylamino or C2-C4 alkoxycarbonyl;
R39 is H or C1-C4 alkyl;
R40 and R41 are independently H or C1-C4 alkyl; or
R40 and R41 are taken together as \u2014(CH2)4\u2014, \u2014(CH2)5\u2014, \u2014CH2CH\u2550CHCH2\u2014 or \u2014(CH2)2O(CH2)2\u2014;
R42 is H or C1-C4 alkyl;
R43 is C1-C4 alkyl;
each R45 is independently halogen, cyano, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C3-C4 alkynyl, C3-C4 haloalkynyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C4-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl;
R62 is H, C1-C4 alkyl or phenyl optionally substituted with 1-3 R65;
R63 is H or C1-C4 alkyl; or
R62 and R63 are taken together as \u2014(CH2)4\u2014 or \u2014(CH2)5\u2014;
R64 is H, C1-C14 alkyl, C1-C3 haloalkyl, C1-C4 alkoxy, phenyl, phenoxy or benzyloxy;
each R65 is independently CH3, Cl or OCH3;
R66 is H, C1-C4 alkyl or C1-4 alkoxy;
R67 is H, C1-C4 alkyl or benzyl;
j is 0 or 1; and
k is 0 or 1;
provided that:
(a) when k is 0, then j is 0;
(b) when R2 is CH2ORa wherein Ra is H, optionally substituted alkyl or benzyl, then R3 is other than cyano;
(c) when R1 is phenyl substituted by Cl in each of the meta positions, the phenyl is also substituted by R7 in the para position;
(d) when R1 is phenyl substituted by R7 in the para position, said R7 is other than tert-butyl, cyano or optionally substituted phenyl;
(e) when R1 is cyclopropyl or isopropyl optionally substituted with 1-5 R6, then R is other than C(\u2550W)N(Rb)S(O)2\u2014Rc\u2014Rd wherein W is O, S, NRe or NORe; Rb is hydrogen, C1-4 alkyl, C2-C6 alkenyl or C2-C6 alkynyl; Rc is a direct bond or CHRf, O, NRe or NORe; Rd is an optionally substituted heterocyclic or carbocyclic aromatic radical having 5 to 6 ring atoms, the radical being optionally condensed with an aromatic or nonaromatic 5- or 6-membered ring; each Re is independently H, C1-C3 alkyl, C1-C3 haloalkyl or phenyl; and Rf is H, C1-C3 alkyl or phenyl; and
(f) the compound of Formula I is other than diethyl 6-amino-5-nitro-2-phenyl-4-pyrimidinemalonate.
2. The compound of claim 1 wherein
R2 is CO2R12, CH2OR13, CH(OR46)(OR47), CHO, C(\u2550NOR14)H, C(\u2550NNR48R49)H, (O)jC(R15)(R16)CO2R17, C(\u2550O)N(R18)R19, C(\u2550S)OR50, C(\u2550O)SR51, C(\u2550S)SR52 or C(\u2550NR53)YR54;
R12 is H, \u2014CHC(O)O(CH2)m, \u2014N\u2550C(R55)R56; or a radical selected from C1-C14 alkyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl, C4-C12 cycloalkylalkyl, C2-C14 alkenyl, C2-C14 alkynyl and phenyl, each radical optionally substituted with 1-3 R27; or
R12 is a divalent radical linking the carboxylic ester function CO2R12 of each of two pyrimidine ring systems of Formula I, the divalent radical selected from \u2014CH2\u2014, \u2014(CH2)2\u2014, \u2014(CH2)3\u2014 and \u2014CH(CH3)CH2\u2014;
R13 is H, C1-C10 alkyl optionally substituted with 1-3 R28, or benzyl;
R14 is H, C1-C4 alkyl, C1-C4 haloalkyl or benzyl;
R17 is C1-C10 alkyl optionally substituted with 1-3 R29, or benzyl;
R18 is H, C1-C4 alkyl, hydroxy, C1-C4 alkoxy or S(O)2R57;
R19 is H or C1-C4 alkyl;
each R27 is independently halogen, cyano, hydroxycarbonyl, C2-C4 alkoxycarbonyl, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, amino, C1-C4 alkylamino, C2-C4 dialkylamino, \u2014CHO(CH2)n or phenyl optionally substituted with 1-3 R44; or
two R27 are taken together as \u2014OC(O)O\u2014 or \u2014O(C(R58)(R58))1-2O\u2014; or
two R27 are taken together as an oxygen atom to form, with the carbon atom to which they are attached, a carbonyl moiety;
each R28 is independently halogen, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, amino, C1-C4 alkylamino or C2-C4 dialkylamino; or
two R28 are taken together as an oxygen atom to form, with the carbon atom to which they are attached, a carbonyl moiety;
each R29 is independently halogen, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, amino, C1-C4 alkylamino or C2-C4 dialkylamino;
each R44 is independently halogen, C1-C4 alkyl, C1-C3 haloalkyl, hydroxy, C1-C4 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 haloalkylthio, amino, C1-C3 alkylamino, C2-C4 dialkylamino or nitro;
R46 and R47 are independently C1-C4 alkyl or C1-C3 haloalkyl; or
R46 and R47 are taken together as \u2014CH2CH2\u2014, \u2014CH2CH(CH3)\u2014 or \u2014(CH2)3\u2014;
R48 is H, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkylcarbonyl, C2-C4 alkoxycarbonyl or benzyl;
R49 is H, C1-C4 alkyl or C1-C4 haloalkyl;
R50, R51 and R52 are H; or a radical selected from C1-C14 alkyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl, C4-12 cycloalkylalkyl, C2-C14 alkenyl and C2-C14 alkynyl, each radical optionally substituted with 1-3 R27;
Y is O, S or NR61;
R53 is H, C1-C3 alkyl, C1-C3 haloalkyl, C2-4 alkoxyalkyl, OH or C1-C3 alkoxy;
R54 is C1-C3 alkyl, C1-C3 haloalkyl or C2-C4 alkoxyalkyl; or
R53 and R54 are taken together as \u2014(CH2)2\u2014, \u2014CH2CH(CH3)\u2014 or \u2014(CH2)3\u2014;
R55 and R56 are independently C1-C4 alkyl;
R57 is C1-C4 alkyl, C1-C3 haloalkyl or NR59R60;
each R58 is independently selected from H and C1-C4 alkyl;
R59 and R60 are independently H or C1-C4 alkyl;
R61 is H, C1-C3 alkyl, C1-C3 haloalkyl or C2-C4 alkoxyalkyl;
m is an integer from 2 to 3; and
n is an integer from 1 to 4.
3. The compound of claim 2 wherein R3 is halogen.
4. The compound of claim 2 wherein R1 is cyclopropyl or phenyl substituted with a halogen, methyl or methoxy radical in the para position and optionally with 1-2 radicals selected from halogen and methyl in other positions; and R4 is \u2014N(R24)R25.
5. The compound of claim 4 wherein R2 is CO2R12, CH2OR13, CHO or CH2CO2R17.
6. The compound of claim 5 wherein R24 is H, C(O)R33 or C1-C4 alkyl optionally substituted with R30; R25 is H or C1-C2 alkyl; or R24 and R25 are taken together as \u2550C(R39)N(R40)R41.
7. The compound of claim 6 wherein R2 is CO2R12; and R24 and R25 are H.
8. The compound of claim 7 wherein R12 is H, C1-C4 alkyl or benzyl.
9. The compound of claim 1 selected from the group consisting of:
methyl 6-amino-5-bromo-2-cyclopropyl-4-pyrimidinecarboxylate,
ethyl 6-amino-5-bromo-2-cyclopropyl-4-pyrimidinecarboxylate,
phenylmethyl 6-amino-5-bromo-2-cyclopropyl-4-pyrimidinecarboxylate,
6-amino-5-bromo-2-cyclopropyl-4-pyrimidinecarboxylic acid monosodium salt,
methyl 6-amino-5-chloro-2-cyclopropyl-4-pyrimidinecarboxylate,
phenylmethyl 6-amino-5-chloro-2-cyclopropyl-4-pyrimidinecarboxylate,
6-amino-5-chloro-2-cyclopropyl-4-pyrimidinecarboxylic acid monosodium salt,
ethyl 6-amino-5-chloro-2-cyclopropyl-4-pyrimidinecarboxylate,
methyl 6-amino-5-chloro-2-(4-chlorophenyl)-4-pyrimidinecarboxylate,
ethyl 6-amino-5-chloro-2-(4-chlorophenyl)-4-pyrimidinecarboxylate,
6-amino-5-chloro-2-(4-chlorophenyl)-4-pyrmidinecarboxylic acid,
ethyl 6-amino-2-(4-bromophenyl)-5-chloro-4-pyrimidinecarboxylate,
methyl 6-amino-2-(4-bromophenyl)-5-chloro-4-pyrimidinecarboxylate, and
6-amino-2-(4-bromophenyl)-5-chloro-4-pyrimidinecarboxylic acid.
10. A herbicidal mixture comprising a herbicidally effective amount of a compound of claim 1 and an effective amount of at least one additional active ingredient selected from the group consisting of an other herbicide and a herbicide safener.
11. A herbicidal mixture comprising synergistically effective amounts of a compound of claim 1 and an auxin transport inhibitor.
12. A herbicidal composition comprising a herbicidally effective amount of a compound of claim 1 and at least one of a surfactant, a solid diluent or a liquid diluent.
13. A method for controlling the growth of undesired vegetation comprising contacting the vegetation or its environment with a herbicidally effective amount of a compound of claim 1.
14. A herbicidal composition comprising a herbicidally effective amount of a compound of claim 1, an effective amount of at least one additional active ingredient selected from the group consisting of an other herbicide and a herbicide safener, and at least one of a surfactant, a solid diluent or a liquid diluent.
15. A compound which is 2-cyclopropyl-1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acid.
16. A compound which is 5-chloro-2-cyclopropyl-1,6-dihydro-6-oxo-4-pyrimidine-carboxylic acid.
17. A compound which is 5,6-dichloro-2-cyclopropyl-4-pyrimidinecarboxylic acid

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A compound of formula (I) or a salt thereof:
wherein
R5 is (a) and attached at any one of positions 4, 5, 6 or 7 of the indole group;
A is a phenyl or a 5 or 6-membered heteroaryl ring;
R1 is hydrogen or up to three substituents independently selected from halogen, C(1-6)alkyl, C(3-6)cycloalkyl, C(1-6)alkoxy, C(3-6)cycloalkyloxy, trifluoromethoxy, difluoromethoxy, trifluoromethyl, cyano, nitro, optionally substituted piperidine, optionally substituted pyrrolidine, optionally substituted phenyl and optionally substituted 5 or 6 membered heteroaryl rings;
when R1 is phenyl, piperidine, pyrrolidine or a 5 or 6 membered heteroaryl ring it may be substituted by up to three substituents selected from halogen, C(1-6)alkyl, C(1-6)alkoxy, trifluoromethoxy, difluoromethoxy, C3-6cycloalkyl, trifluoromethyl and cyano;
R2 is hydrogen or up to three substituents independently selected from halogen, C(1-4)alkyl, C(1-4)alkoxy, trifluoromethoxy, difluoromethoxy, trifluoromethyl and cyano;
one of R3 and R4 is hydrogen or C(1-6)alkyl and the other is Z\u2014COOH or C(1-6)alkylOH;
Z is absent, C(1-6)alkyl or C(2-6)alkenyl;
when Z is C(1-6)alkyl it is optionally interrupted by cyclopropyl, piperidinyl, azetidinyl, pyrrolidinyl, N or O and optionally substituted by O, cyclopropyl halogen or methyl, when Z is C(2-6)alkenyl it is optionally substituted by methyl.
R6 is hydrogen or C(1-6)alkyl.
2. A compound of formula (I) of claim 1, or a salt thereof, wherein:
R5 is (a) and attached at positions 6 or 7 of the indole group;
A is phenyl or pyridyl;
R1 is C(1-6)alkoxy and one other substituent independently selected from halogen, C(1-6)alkoxy, trifluoromethyl, C(1-6)alkyl and cyano;
R2 is halogen or hydrogen;
one of R3 and R4 is hydrogen and the other is Z\u2014COOH or CH2OH;
Z is C(1-6)alkyl optionally interrupted by cyclopropyl, piperidinyl, azetidinyl, pyrrolidinyl, N or O and optionally substituted by O, cyclopropyl, halogen or methyl, or Z is C(2-6)alkenyl optionally substituted by methyl; and
R6 is hydrogen, methyl, ethyl, propyl or butyl.
3. A compound selected from:
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropanoic acid;
3-6-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-6-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropanoic acid;
3-6-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
5-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indole-2-carboxylic acid;
3-5-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-2-ylpropanoic acid;
(2E)-3-5-(5-{3-cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-2-yl-2-propenoic acid;
5-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-2-ylmethanol;
5-{3-2-(Hydroxymethyl)-1H-indol-5-yl}-1,2,4-oxadiazol-5-yl-2-(1-methylethyl)oxybenzonitrile;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropanoic acid;
3-(7-{5-6-(1-Methylethyl)oxy-5-(trifluoromethyl)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-7-(5-{5-Methyl-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-1-Methyl-7-(5-{5-methyl-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-(7-{5-6-(1-Methylethyl)oxy-5-(methyloxy)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-(4-Fluoro-7-{5-6-(1-methylethyl)oxy-5-(trifluoromethyl)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-(4-Fluoro-7-{5-6-(1-methylethyl)oxy-5-(methyloxy)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-ethyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-propyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-(1-methylethyl)-1H-indol-3-ylpropanoic acid;
3-1-butyl-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-(2-methylpropyl)-1H-indol-3-ylpropanoic acid;
7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-O-1H-indol-3-ylacetic acid;
4-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylbutanoic acid;
4-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl-4-oxobutanoic acid;
5-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpentanoic acid;
4-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylbutanoic acid;
(2R)-3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-yl-2-methylpropanoic acid;
(2E)-3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-yl-2-propenoic acid;
(2Z)-3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-yl-2-propenoic acid;
trans-2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylcyclopropanecarboxylic acid;
cis-2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylcyclopropanecarboxylic acid;
3-(7-{5-3,4-bis(ethyloxy)phenyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-(7-{5-3,4-bis(ethyloxy)phenyl-1,2,4-oxadiazol-3-yl}-1-methyl-1H-indol-3-yl)propanoic acid;
3-(7-{5-3,4-bis(methyloxy)phenyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-(7-{5-3,4-bis(methyloxy)phenyl-1,2,4-oxadiazol-3-yl}-1-methyl-1H-indol-3-yl)propanoic acid;
3-(7-{5-3-chloro-4,5-bis(ethyloxy)phenyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-\u03b2-alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}glycine;
1-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-4-piperidinecarboxylic acid;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-D-alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-L-alanine;
3-({7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}amino)butanoic acid;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-N-methylglycine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-N-methyl-D-alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-N-methyl-L-alanine;
N-{7-(5-{3-cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-N-methylglycine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}glycine;
1-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}-4-piperidinecarboxylic acid;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}-\u03b2-alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}-D-alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}-L-alanine;
3-({7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylmethyl}amino)butanoic acid;
N-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylethyl}-\u03b2-alanine;
N-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylethyl}glycine;
N-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}glycine;
N-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}- -alanine;
1-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}-4-piperidinecarboxylic acid;
1-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}-3-azetidinecarboxylic acid;
1-({2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}amino)cyclopropanecarboxylic acid;
1-{2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}-L-proline;
N-{3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropyl}glycine;
N-{3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropyl}-N-methylglycine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylcarbonyl}glycine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylcarbonyl}- -alanine;
4-({7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylcarbonyl}amino)butanoic acid;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylcarbonyl}-N-methyl- -alanine;
N-{7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylcarbonyl}- -alanine;
N-{3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoyl}glycine;
1-{6-(5-{5-chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylmethyl}-4-piperidinecarboxylic acid;
({2-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylethyl}oxy)acetic acid;
({3-7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropyl}oxy)acetic acid;
3-6-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-6-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-3-ylpropanoic acid;
3-(6-{5-6-(1-Methylethyl)oxy-5-(trifluoromethyl)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-6-(5-{5-Fluoro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-6-(5-{5-Methyl-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-1-Methyl-6-(5-{5-methyl-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-ylpropanoic acid;
3-(6-{5-6-(1-Methylethyl)oxy-5-(methyloxy)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-3-yl)propanoic acid;
3-5-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-2-ylpropanoic acid;
3-5-(5-{3-cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-2-ylpropanoic acids;
3-5-(5-{5-chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1H-indol-2-ylpropanoic acid;
3-5-(5-{5-chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indol-2-ylpropanoic acid;
3-(5-{5-6-(1-methylethyl)oxy-5-(trifluoromethyl)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-2-yl)propanoic
3-(5-{5-6-(1-methylethyl)oxy-5-(methyloxy)-3-pyridinyl-1,2,4-oxadiazol-3-yl}-1H-indol-2-yl)propanoic
7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1H-indole-3-carboxylic acid;
7-(5-{3-chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-1-methyl-1H-indole-3-carboxylic acid;
3-7-(5-{3-cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-4-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Chloro-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1H-indol-3-ylpropanoic acid;
3-7-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-6-fluoro-1-methyl-1H-indol-3-ylpropanoic acid;
3-6-(5-{3-Chloro-4-(1-methyl ethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-6-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-6-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-5-fluoro-1H-indol-3-ylpropanoic acid;
3-5-(5-{3-Chloro-4-(1-methyl ethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-7-fluoro-1H-indol-2-ylpropanoic acid;
3-5-(5-{3-Cyano-4-(1-methylethyl)oxyphenyl}-1,2,4-oxadiazol-3-yl)-7-fluoro-1H-indol-2-ylpropanoic acid; and
3-5-(5-{5-Chloro-6-(1-methylethyl)oxy-3-pyridinyl}-1,2,4-oxadiazol-3-yl)-7-fluoro-1H-indol-2-ylpropanoic acid;
and salts thereof.
4.-11. (canceled)
12. A pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof according to claim 1.
13. A method of treatment for conditions or disorders in mammals including humans which can be mediated via the S1P1 receptor.
14. A method of treatment according to claim 13, wherein the condition is multiple sclerosis.